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Insurance status predicts access to care and
outcomes of vascular disease
Jeannine K. Giacovelli, MD, MPHa,b,c Natalia Egorova, MPH, PhD,b Roman Nowygrod, MD,a
Annetine Gelijns, PhD,b K. Craig Kent, MD,a and Nicholas J. Morrissey, MD,a New York, NY
Objective: To determine if insurance status predicts severity of vascular disease at the time of treatment or outcomes
following intervention.
Methods: Hospital discharge databases from Florida and New York from 2000-2005 were analyzed for lower extremity
revascularization (LER, n  73,532), carotid revascularization (CR, n  116,578), or abdominal aortic aneurysm repair
(AAA, n  35,593), using ICD-9 codes for diagnosis and procedure. The indications for intervention as well as the
post-operative outcomes were examined assigning insurance status as the independent variable. Patients covered under a
variety of commercial insurers, as well as Medicare, were compared to those who either had no insurance or were covered by
Medicaid.
Results: Patients without insurance or with Medicaid were at significantly greater risk of presenting with a ruptured AAA
compared to insured (non-Medicaid) patients; while insurance status did not seem to impact post-operative mortality
rates for elective and ruptured AAA repair. The uninsured or Medicaid recipients presented with symptomatic carotid
disease nearly twice as often as the insured, but stroke rates after CR did not differ significantly based on insurance status.
Patients with Medicaid or without insurance were more likely to present with limb threatening ischemia than
claudication. In contrast to AAA repair and CR, the outcomes of LER were worse in the uninsured and Medicaid
beneficiaries who had higher rates of post-revascularization amputation compared to the insured (non-Medicaid) group.
Conclusion: Insurance status predicts disease severity at the time of treatment, but once treated, the outcomes are similar
among insurance categories, with the exception of lower extremity revascularization. This data suggests inferior access to
preventative vascular care in the Medicaid and the uninsured populations. ( J Vasc Surg 2008;48:905-11.)It is well-known that health insurance is a critical deter-
minant of adequate access to preventative and therapeutic
care. Research conducted in various fields of medicine and
surgery has revealed disparities in the utilization of medical
care, treatment of disease, and outcome of treatment as a
function of insurance status.1-7 Medicaid patients and the
uninsured are much less likely to undergo coronary artery
bypass graft (CABG) surgery or percutaneous transluminal
coronary angioplasty (PTCA) for coronary atherosclerosis
and are at increased risk of in-hospital mortality after a
myocardial infarction (MI).4,7 It has also been demon-
strated that Medicaid recipients and the uninsured are
found to be in the more advanced stages of cancer at
diagnosis and are at increased risk of perioperative mortality
following colorectal surgery for carcinoma when compared
to those with other insurance coverage.1,3,5,6 Studies have
also shown that uninsured individuals are less likely to have
a regular source of care, such as a primary care physician,
and instead use the emergency room to fill this role. The
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doi:10.1016/j.jvs.2008.05.010uninsured are less likely to use preventative services, less
likely to fill prescriptions, and ultimately have worse health
outcomes.7-10 The purpose of this study was to further
explore these disparities in the context of vascular disease.
There have been few studies that comprehensively ex-
amine the role of health insurance status in outcomes of
patients with peripheral arterial disease. The factors in-
volved in the development and progression of arterial pa-
thologies are numerous and complex. However, it is prob-
able that risk factor modification and early detection could
reduce the severity of disease at presentation and improve
the outcome of treatment. The ability to provide the proper
services to patients such as education, screening, frequent
monitoring, and early intervention may depend on ade-
quate access to care. The objectives of this analysis were to
determine if insurance status predicts disease severity at the
time of treatment for three common vascular diseases (ab-
dominal aortic aneurysm [AAA], carotid stenosis, and
lower extremity occlusive disease), and to determine
whether it predicts outcome following treatment.
METHODS
Data sources. Databases for inpatient hospitalizations
from New York State Health Department Statewide Plan-
ning and Research Cooperative System (SPARCS) and
Florida State Agency for Healthcare Administration, years
2000-2005, were queried for patient information includ-
ing; primary and secondary diagnoses, and primary and
secondary procedures by International Classification of
Disease, 9th Revision, Clinical Modification (ICD-9-CM)
codes. These are publicly available discharge databases
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years specified. New York and Florida are populous states
which adequately represent the national population distribu-
tion within insurance categories. These databases contain
coded clinical and demographic information about each hos-
pital discharge, including the ethnicity of the patient.
Patient population. Patients were designated into in-
surance groups by principle payer codes. Three groups were
analyzed: insured (non-Medicaid), Medicaid, and unin-
sured. The insured (non-Medicaid) group included pa-
tients with the following principle payer: Medicare, Medi-
care HMO, Medicaid HMO, commercial indemnity plan,
commercial HMO, commercial PPO, Worker’s Compen-
sation, CHAMPUS (The Civilian Health and Medical Pro-
gram of the Uniformed Services) Veterans Affairs, Blue
Cross, other state/local government insurance, and other
federal programs. Medicaid HMO reimbursement is typi-
cally higher than Medicaid fee-for-service and more com-
parable to payers in the insured group. Moreover, HMOs
are typically organized based on preventative care model
which further distinguish them from non-HMOMedicaid.
(To simplify presentation, we will refer to this group as
insured.) Patients were designated as Medicaid beneficia-
ries if their principle payer was Medicaid or uninsured if
their principle payer code was self pay. Patients with payer
code designated “no charge” or “charity” were excluded
from this analysis.
Treatment groups were identified by matching all rele-
vant ICD-9 procedure codes with the related primary and
secondary diagnosis codes. A complete list of procedure
and diagnosis codes is available online (Table I, online
only).The indication for, and the outcomes of three proce-
dures were analyzed including AAA repair, carotid revascu-
larization (CR) and lower extremity revascularization
(LER). Disease severity at time of treatment for patients
undergoing AAA repair was categorized as ruptured (emer-
gent) (441.3) or elective (441.4). We examined post-
operative mortality of all AAA repairs and also stratified by
disease severity. Patients who underwent carotid proce-
dures were divided into two groups: symptomatic and
asymptomatic. The symptomatic patients presented preop-
eratively with any one of the following diagnoses (in the
primary or any secondary coding positions): occlusion and
stenosis of carotid artery with cerebral infarction (433.11),
occlusion and stenosis of multiple and bilateral arteries with
cerebral infarction (433.31), unspecified transient cerebral
ischemia (435.9), retinal vascular occlusion (362.3) and
retinal ischemia (362.84). Asymptomatic patients pre-
sented with one of the following two diagnoses (primary or
any secondary positions): occlusion and stenosis of carotid
or multiple and bilateral arteries without mention of cere-
bral infarction, respectively (433.10 or 433.30) and none
of the symptomatic codes. We analyzed post-operative
stroke (997.02) for all patients undergoing carotid revas-
cularizations and also stratified groups by symptomatology.
Patients who underwent LER with diagnoses of rest
pain (440.22), ulceration (440.23 or 707.1), or gangrene
(440.24 or 785.4) were included in the limb threateningischemia group and were compared to patients with a
diagnosis of claudication (440.21) alone. An LER followed
by major amputation during the same hospitalization were
considered failed LER. The absence of major amputation
(84.13-84.17) following LER was considered a successful
procedure.
We assessed the relationship between the following co-
morbidities and outcome: diabetes, hypertension, coronary
artery disease, renal failure, emphysema, and disorders of lipid
metabolism. A list of ICD9 diagnosis codes representing
comorbidities is available from our earlier publications.11,12
Statistical analysis. Statistical analysis was performed
using the SAS system software (SAS Institute Inc., Cary,
NC). Univariate analyses of proportions were performed
using the 2 test or the Fisher exact test, where appropriate.
Means were compared with the Student t-test. Statistical
significance was expressed as both P-values and 95% confi-
dence intervals (CI). Confidence intervals for proportions
were calculated using normal approximation to the bino-
mial distribution. Predictors of clinical manifestation of
disease and major outcomes after surgical interventions
were identified with multivariable logistic regression analy-
sis. Consideration was given to the unequal age distribution
across insurance groups and was adjusted for in our regres-
sion models. Patients’ demographics and baseline comor-
bid conditions with significant univariate association to
outcomes were included in the models. Results of the
multivariate logistic regression are presented as odds ratios
(OR) with the appropriate 95% CI. The insured group was
chosen as the control.
RESULTS
We identified significant differences in demographics
between the insurance groups undergoing the selected
vascular interventions (Table II). Patients without insur-
ance were significantly younger compared to the insured
group, with the largest difference found among LER pa-
tients (approximately 11 years younger). The percentage of
blacks and Hispanics was highest in the Medicaid group
(P .05), while the proportion of white non-Hispanics was
significantly greater in the insured population (P .0001).
We also identified significant differences in comorbidi-
ties between the insurance groups (Table II). For all three
arterial disorders, the prevalence of cardiovascular comor-
bidities, including hypertension and hyperlipidemia, was
uniformly less in the uninsured versus the insured or the
Medicaid populations. Our data also show a substantially
higher proportion of diabetics among Medicaid patients.
This was the case for all three arterial disorders, but most
prominent in CR and LER.
Adjusting for patients’ demographics and comorbidi-
ties, we examined whether insurance status was an indepen-
dent predictor of disease severity at time of treatment and of
outcome of intervention. Tables III, IV, and V illustrate the
outcomes of this analysis for AAA repair, CR, and LER,
respectively.
For aneurysmal disease, Medicaid recipients were
found to be 1.68 times more likely to present with an AAA
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4.17 times more likely to have ruptured prior to surgery.
For Medicaid patients, the overall risk of post-operative
death following AAA repair (both elective and emergent)
was not significantly increased compared to insured pa-
tients; however, uninsured patients were 3.1 times more
likely to die following AAA repair compared to insured
patients (Table III). When stratified by procedure type
(elective or emergent, [Table II]), the odds of post-
operative death after elective AAA were not higher for the
uninsured: OR 1.016, 95% CI 0.44-2.33, or the Medic-
aid population: OR  0.92, 95% CI 0.47-1.84 when
Table II. Patient demographics and comorbidities and th
Insured
(%)
Med
(%
Abdominal Aortic Aneurysm Repair
(n  35,593) 98 1
Age (years) 73.35 64
Male 79.48 73
Black non-Hispanic 2.79 11
Hispanic 3.14 19
White non-Hispanic 86.89 50
Diabetes 12.16 15
Coronary 41.80 36
Renal 4.79 5
Hyperlipidemia 14.99 12
Emphysema 32.98 32
Hypertension 61.76 64
Mortality: Elective Repairs 3.34 2
Mortality: Emergent Repairs 48.51 38
Carotid Revascularization (n  116,578) 97.4 1
Age (years) 71.79 62
Male 58.22 48
Black non-Hispanic 2.47 8
Hispanic 3.05 13
White non-Hispanic 87.09 60
Diabetes 26.86 39
Coronary 43.01 44
Renal 2.43 2
Hyperlipidemia 20.06 21
Emphysema 17.42 20
Hypertension 72.42 73
Post-operative stroke 1.19 1
Lower Extremity Revascularization
(n  73,532) 94.2 4
Age (years) 70.68 60
Male 57.72 52
Black non-Hispanic 11.10 23
Hispanic 5.79 17
White non-Hispanic 74.55 42
Diabetes 47.26 60
Coronary 43.26 38
Renal 13.03 11
Hyperlipidemia 13.19 12
Emphysema 21.26 19
Hypertension 66.90 65
Amputation after LER 5.19 8compared to the insured.Similarly, Medicaid patients and those without insur-
ance had a higher probability of symptoms, such as stroke,
transient ischemic attack, or retinal artery occlusion, prior
to carotid revascularization (OR  1.61, 95% CI 1.40-
1.84, OR 1.93, 95% CI 1.63-2.30, respectively) without
significantly increasing the risk of post-operative stroke
(Tables II and III).
When analyzing lower extremity peripheral vascular
disease, we found Medicaid recipients to be at the highest
risk (OR  2.34, 95% CI 2.14-2.56) of presenting with
limb threatening ischemia, including rest pain, ulceration
or gangrene, even higher than the uninsured (Table V).
sociation with insurance status
Uninsured
(%)
P-value for pairwise comparisons
Medicaid vs
insured
Medicaid vs
uninsured
Uninsured vs
insured
0.98
65.62 .0001 .29 .0001
84.24 .002 .0003 .03
5.16 .0001 .001 .008
14.04 .0001 .03 .0001
67.91 .0001 .0001 .0001
11.46 .02 .07 .64
25.21 .02 .0009 .0001
2.01 .78 .02 .02
9.17 .23 .10 .002
27.51 .85 .13 .03
57.59 .26 .051 .11
2.58 .37 .95 .52
49.14 .10 .16 .89
0.9
62.33 .0001 .83 .0001
57.90 .0001 .0001 .83
3.28 .0001 .0001 .10
6.55 .0001 .0001 .0001
75.34 .0001 .0001 .0001
25.14 .0001 .0001 .21
34.20 .15 .0001 .0001
0.87 .93 .003 .001
19.65 .048 .15 .74
15.61 .0001 .0004 .12
67.27 .20 .0001 .001
0.77 .72 .39 .22
1.1
59.34 .0001 .001 .0001
63.18 .0001 .0001 .002
18.6 .0001 .002 .0001
10.98 .0001 .0001 .0001
56.46 .0001 .0001 .0001
47.80 .0001 .0001 .76
29.20 .0001 .0001 .0001
4.26 0.01 .0001 .0001
9.30 0.37 .01 .002
17.44 0.03 .14 .01
55.94 .059 .0001 .0001
6.20 .0001 .02 .21eir as
icaid
)
.2
.80
.44
.78
.86
.12
.94
.26
.08
.93
.56
.43
.49
.57
.6
.42
.41
.56
.73
.69
.65
.45
.88
.94
.73
.10
.7
.85
.47
.91
.91
.11
.56
.55
.54
.66
.75
.36Those withMedicaid insurance were also at the highest risk
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1.34-1.74). While uninsured status was also associated with
higher likelihood of presentingwith limb threatening ische-
mia (OR  2.23, 95% CI 1.88-2.65), this group did not
appear to have a higher risk of amputation following bypass
(Table II).
With regard to demographic characteristics and comor-
bidities, we found across all three procedures that renal
failure and black ethnicity significantly predicted presenta-
Table III. Abdominal aortic aneurysm repair: baseline
predictors of ruptured AAA at the time of treatment and
mortality after AAA (elective and emergent) repair based
on results of multivariable logistic regression analysis and
insured as the control group
Variables
Presenting with
rupture Death
OR 95% CL OR 95% CL
Age 1.02 1.01-1.02 1.05 1.05-1.06
Male 0.89 0.82-0.97 0.67 0.61-0.73
Hispanic 1.06* 0.89-1.27 1.41 1.16-1.71
Black non-Hispanic 1.44 1.21-1.72 1.30 1.05-1.61
Diabetes 0.81 0.72-0.91 0.85 0.75-0.98
Renal Failure 2.47 2.17-2.82 3.32 2.89-3.83
Emphysema 0.90 0.84-0.97 0.91 0.84-0.99
Hypertension 0.52 0.49-0.56 0.42 0.39-0.45
Coronary disease 0.46 0.42-0.49 0.52 0.47-0.56
Hyperlipidemia 0.39 0.34-0.45 0.31 0.25-0.37
Medicaid 1.68 1.28-2.20 1.25* 0.87-1.80
Uninsured 4.17 3.29-5.29 3.10 2.31-4.16
AAA,Abdominal aortic aneurysm;OR, odds ratio;CL, confidence limits for
odds ratio.
*P  .05.
Table IV. Carotid revascularization: baseline predictors
of symptomatic carotid disease at the time of treatment
and post-operative stroke based on results of
multivariable logistic regression analysis and insured as
the control group
Variables
Presenting with
symptoms PO Stroke
OR 95% CL OR 95% CL
Age 0.995 0.93-0.997 1.01 1.003-1.015
Male 1.09 1.04-1.13 .94* 0.84-1.05
Hispanic 1.42 1.28-1.58 1.15* 0.86-1.54
Black non-Hispanic 1.53 1.36-1.70 1.40 1.04-1.87
Diabetes 1.01* 0.96-1.06 1.03* 0.91-1.16
Renal Failure 1.46 1.30-1.65 1.91 1.47-2.48
Emphysema 1.19 1.12-1.25 1.53 1.35-1.73
Hypertension 1.03* 0.99-1.09 0.87 0.77-0.97
Coronary disease 0.82 0.79-0.86 0.84 0.75-0.94
Hyperlipidemia 0.89 0.84-0.94 0.79 0.68-0.91
Medicaid 1.61 1.40-1.84 0.95* 0.61-1.47
Uninsured 1.93 1.63-2.30 0.69* 0.34-1.39
PO, Post-operative; OR, odds ratio; CL, confidence limits for odds ratio.
*P  .05.tion with more severe disease, as well as worse outcomewith intervention. AlthoughHispanics withMedicaid fared
better thanHispanics without insurance,Hispanic ethnicity
significantly increased the likelihood of presentation with
advanced carotid and lower extremity disease, increased the
risk of death following AAA repair and amputation follow-
ing LER. Diabetes reduced the likelihood that an aneurysm
was found to be ruptured at the time of treatment (OR 
0.81, 95% CI 0.72-0.91) and reduced the risk of mortality
following AAA repair (OR  0.85, 95% CI 0.75-0.98).
However, this disease significantly increased the likelihood
that a limb’s viability was threatened at the time of treat-
ment and increased the risk of amputation following LER.
Both of these findings have been made by others.13-18
DISCUSSION
We chose to compare three groups based on insurance
status, and analyzed three common arterial pathologies,
(AAA, carotid, and lower extremity occlusive disease), in
order to determine if insurance status predicts disease se-
verity at time of treatment and outcome following treat-
ment. While our results with respect to insurance status do
not definitively prove that Medicaid patients and the unin-
sured have worse access to vascular care, they support this
hypothesis and add to insights derived from earlier stud-
ies.19-21 While the findings are clear, the explanation for
these findings remains to be fully determined. Indeed, the
disparate results may be due to different factors for different
pathological entities.
Among AAA patients, we found that Medicaid benefi-
ciaries and the uninsured were at significantly higher risk of
emergent repair than those with other coverage. In fact, the
risk of presenting with rupture is two to three times as likely
Table V. Lower extremity revascularization: baseline
predictors of limb threatening ischemia at the time of
treatment and major amputations after LER based on
results of multivariable logistic regression analysis and
insured as the control group
Variables
Presenting with
limb threatening
ischemia Major amputation
OR 95% CL OR 95% CL
Age 1.039 1.03-1.04 1.01 1.00-1.01
Male 0.83 0.80-0.86 0.952* 0.891-1.017
Hispanic 1.91 1.76-2.06 1.67 1.49-1.87
Black non-Hispanic 2.64 2.48-2.82 2.15 1.97-2.34
Diabetes 3.23 3.12-3.35 1.16 1.08-1.24
Renal Failure 4.77 4.45-5.12 2.65 2.44-2.87
Emphysema 1.28 1.23-1.33 1.24 1.15-1.35
Hypertension 0.68 0.65-0.70 0.60 0.56-0.64
Coronary disease 0.77 0.75-0.80 0.70 0.65-0.75
Hyperlipidemia 0.57 0.54-0.60 0.48 0.42-0.56
Medicaid 2.34 2.14-2.56 1.52 1.34-1.74
Uninsured 2.23 1.88-2.65 1.18* 0.88-1.59
OR, Odds ratio; CL, confidence limits for odds ratio.
*P  .05.in the uninsured. One explanation for this finding is that
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early detection of AAA, and hence fewer elective repairs.
Disease severity may be the best predictor of outcomes
following AAA repair, as the mortality rate for emergent
repair consistently approaches 50% compared to 5% or less
for elective repair.22,23 Therefore, it is not surprising that
the uninsured, who are more likely to be treated for an
already ruptured AAA, have an overall post-operative mor-
tality rate more than double seen in patients with insurance.
This finding may well be related to the high number of
ruptured AAAs in the uninsured cohort and the anticipated
poor outcome of the emergent procedure. The excess
mortality and healthcare costs associated with the higher
rate of emergent AAA repairs has not been quantified,
however, one might anticipate it to have a considerable
public health impact. Of note, the uninsured, Medicaid,
and insured patients appear to have equivalent outcomes
following treatment of AAAwhen the diagnosis is electively
made. Boxer et al24 have previously reported a significant
relationship between insurance status, aneurysm presenta-
tion and operative mortality using The Nationwide Inpa-
tient Sample (NIS) database. Medicare beneficiaries were
excluded from that analysis and consequentially only 5,363
patients, all less than 65 years of age, were included in their
study. Similar to the findings reported here, the authors
described an increased risk of rupture (OR  2.3, 95% CI
1.5-3.5) in patients who were uninsured.24 However, they
did not observe Medicaid insurance to be associated with
an increased risk of rupture. While our results show that
patients with Medicaid or no insurance are more likely to
rupture and die from AAA, it is also clear that such patients
have the same potential as insured patients for favorable
outcomes if they are treated in a timely manner.
In carotid occlusive disease, we found that Medicaid
recipients and the uninsured have more strokes, transient
cerebral ischemia, and ocular complications prior to receiv-
ing CR. This finding of advanced symptomatology at the
time of treatment amongMedicaid and uninsured patients,
may be due to poor access to preventative education re-
garding modifiable health factors, as well as lower rates of
screening for asymptomatic carotid disease. Shen and
Washington21 recently reported that carotid endarterec-
tomy, in the absence of acute stroke symptoms, is more
frequently performed in those with insurance coverage
other than Medicaid, and concluded that access to preven-
tative care is greater in those with private insurance. Proper
access to screening and prophylactic intervention in the
underinsured may significantly reduce strokes by allowing
for treatment of asymptomatic patients with high-risk le-
sions. Although the risk of late or symptomatic presenta-
tion was increased in Medicaid beneficiaries and the unin-
sured, post-revascularization stroke risks were not
significantly increased when compared to the insured co-
hort. Once again, when patients are detected prior to
symptoms, they tend to have similar outcomes regardless of
their insurance status.
Our analysis of LER revealed the Medicaid population
to be at the highest risk for presenting with limb threaten-ing ischemia prior to intervention and the most likely to
require subsequent amputation. Conversely, those with
insurance were most often treated for claudication as the
indication for LER. The uninsured also present with a
higher incidence of limb threatening ischemia, but there
was no statistical difference in their risk of amputation
following bypass compared to the insured. A recent study
by Eslami et al25 using the NIS dataset, also found an
association between payer, presentation, and outcome of
lower extremity peripheral vascular disease, but the unin-
sured were excluded in their analysis. This group also found
thatMedicaid beneficiaries presentedmore commonly with
ischemic gangrene and were at 1.91 times the risk for
primary amputation when compared to those on Medicare
or privately insured. Although, in each of these analyses a
significantly higher prevalence of diabetes was demon-
strated within the Medicaid population, insurance status
remained a predictor of limb threatening ischemia and
amputation after controlling for coexisting comorbidities.
The obvious explanation for the increased rate of amputa-
tion following revascularization in Medicaid patients is that
these patients present with more advanced disease requir-
ing more complex difficult revascularization and may have
tissue loss too severe to permit limb salvage. The younger
age associated with patients in the Medicaid group makes
sense given the distribution of coverage based on age.
Patients presenting at younger age with limb threatening
ischemia may have more severe disease and poorly con-
trolled risk factors, thus making them less likely to have
successful limb salvage. However, medicaid remains a fac-
tor which may predict poorer outcomes following LER
after controlling for age.
Although discrepancies in the distribution of demo-
graphic variables and comorbidities existed between the
insurance groups, as well as between the three arterial
pathologies, certain trends were quite apparent: blacks and
Hispanics were more likely to be uninsured or covered by
Medicaid than white non-Hispanics. Moreover, black or
Hispanic ethnicity was often associated with an increased
risk of late presentation of disease or poor outcome. Inter-
estingly, hypertension, hyperlipidemia, or coronary diseases
were almost uniformly protective of poor outcomes and of
advanced disease presentation. These diagnoses were most
prevalent in patients with insurance coverage. The reason
uninsured patients would have fewer cardiovascular risk
factors is unclear, albeit one possibility is that these comor-
bidities existed but were undiagnosed in these patients. The
increased prevalence of these three illnesses in the insured
population may reflect two facts. First, in order to be
diagnosed and coded for one of these comorbidities a
patient must already have access to care, and second, effec-
tive treatment of these comorbidities ultimately protects
patients; ie, medications used to treat these conditions,
such as beta-blockers and statins, are protective against
progression of vascular disease and improve outcomes.26,27
Therefore, the higher prevalence of these seemingly bene-
ficial diagnoses in the insured is likely a surrogate for the
greater access of these patients to medical care. These
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the delivery of preventative vascular care.
There are several limitations inherent in analyzing an
administrative dataset. Although these datasets are main-
tained by the New York and Florida Departments of Health
and capture all hospitalizations in these states, diagnosis
codes are broad and vague and provide limited detail.
Illness severity may be inconsistently recorded resulting in
coding inaccuracies and oversights. For example, in our
analysis of carotid occlusive disease, assigning symptomatic
status or post-operative stroke prior to 2005 when the
specific code was introduced was particularly difficult, yet it
is probable that if errors in coding did occur, they occurred
at similar frequencies across insurance groups. Another
possible explanation for the implausible protective affect of
certain comorbidities in our logistic regression analysis may
be that comorbidities are coded less commonly in patients
who die than in patients discharged alive.28 In addition,
discharge databases lack physiologic information and do
not provide insight regarding patient preferences for treat-
ment options or compliance. Moreover, patient identifiers
are typically absent, precluding longitudinal analyses. Given
the large numbers of patients in these databases, it may be
possible to detect significant differences simply because of
large sample size. The use of multivariate analysis should
eliminate the impact of detecting positive findings based
solely on sample size. All of these factors limit the precision
of analysis when using large datasets. Despite these limita-
tions, these findings which remain strongly positive after
multivariate analysis, can provide powerful evidence of
trends and allow hypotheses to be developed and tested
with more rigid scientific methods.
CONCLUSION
In conclusion, our data support and expand on previ-
ously reported relationships between insurance status and
disease severity at the time of treatment for aneurysmal,
lower extremity, and carotid artery disease. There also
appears to be a relationship between insurance status and
amputation as the outcome of LER. Vascular patients with
Medicaid or without insurance have increased mortality,
pre-operative stroke, and limb loss following LER. The
advanced symptomatology and unfavorable outcomes in
these patients, which are likely related to delayed diagnosis,
are liable to negatively affect their quality of life and to
result in substantially higher cost of care.
The public health implications surrounding these dis-
parities in vascular disease are significant and preventable.
Perhaps this paper may encourage efforts towards public
education and improved awareness of warning signs related
to aneurysmal, lower extremity, and carotid diseases. Im-
portantly this study illustrates that Medicaid insurance may
not be adequate coverage for vascular patients and enroll-
ment may not overcome the barriers to vascular care asso-
ciated with being uninsured. This analysis raises important
questions regarding the inequalities in levels of care given
to those with and without insurance coverage.AUTHOR CONTRIBUTIONS
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RECOUP THE LOUPES 
Despite extremely limited resources, surgeons in developing countries work to provide their 
patients with the best possible care. For many of these surgeons, technology such as loupes, 
which facilitate delicate procedures, is simply out of reach.  
One year ago, Loupes Around The World distributed its first pair of loupes to a plastic surgeon
in Phnom Penh, Cambodia. Before Loupes Around The World, this surgeon commonly 
repaired cleft lips and palates, and treated trauma patients with maxillofacial injuries without 
the benefit of surgical magnification. Since then, this not-for-profit organization has provided 
loupes to surgeons from Panama to India and continues to receive requests from surgeons 
around the world.  
Loupes Around The World is now recycling donated loupes via a program called “Recoup the 
Loupes.” Surgeons with unused loupes are asked to send them to the foundation; there, repairs 
can be made to adjustable loupes, and the telescopes from fixed loupes can be installed into 
new lenses and frames. For fixed loupes, optical measurements are taken to ensure that the 
loupes will meet the needs of each individual surgeon. 
Please send your unused loupes to:  
David C. Knight, M.D., F.A.C.S. 
Loupes Around The World 
c/o Surgical Associates of Waterbury 
1211 West Main St. 
Waterbury, CT 06708 
Loupes Around The World accepts loupes made by any manufacturer. For more information 
about Loupes Around The World, as well as information about how to contribute, please visit: 
www.loupesaroundtheworld.org. Upon receiving loupes, a letter of acknowledgment will be 
sent to the donor for tax purposes. Loupes Around the World is a 501(c)3 tax-exempt 
organization.  
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Category ICD9 Procedure codes ICD9 Diagnosis codes
Carotids OPEN 433.1 Carotid artery occlusion and stenosis
38.12 Carotid endarterectomy 433.3 Multiple/bilateral carotid occlusion
ENDO 435.9 Transient cerebral ischemia
39.50 Angioplasty or atherectomy of non-coronary vessel 362.3 Retinal vascular occlusion, unspecified
39.90 Insertion of non-drug-eluting, non-coronary
artery stent(s)
362.8 Other retinal disorders
AAA* OPEN 441.4 Abdominal aneurysm without mention of rupture
38.34 Resection of abdominal aorta with anastomosis 441.9 Aortic aneurysm of unspecified site without
mention of rupture38.44 Resection of abdominal aorta with replacement
38.64 Other excision of vessels, abdominal aorta
39.52 Other repair of vessels, abdominal aorta
ENDO
39.71 Endovascular implantation of graft in abdominal
aorta
LER** OPEN 440.2 Atherosclerosis of extremities
39.29 Other (peripheral) vascular shunt or bypass
(excludes: peritoneovenous shunt)
250.7 Diabetes with peripheral circulatory disorders
443.9 Peripheral vascular disease
38.08 Embolectomy/thrombectomy lower limb arteries 444.22 Arterial embolism and thrombosis of LE***
38.18 Endarterectomy lower limb arteries 442.3 Aneurysm of artery of LE
38.38 Resection of lower limb arteries with anastomosis 996.74 Other complications of internal prosthetic
device, implant and graft due to other vascular device,
implant, and graft
38.48 Resection of lower limb arteries with replacement
38.88 Clamping/ligation/division/ occlusion of lower
limb arteries
ENDO
39.50 Angioplasty or atherectomy of non-coronary vessel
39.90 Insertion of non-drug-eluting, non-coronary
artery stent(s)
Amputations MAJOR 445.02 Atheroembolism. Lower extremity
440.20 ASO–Native arteries/extremities unspecified
440.22 ASO–Native arteries/extremities w/rest pain
440.23 ASO–Native arteries/extremities, w/ulceration
440.24 ASO–Native arteries/extremities, w/gangrene
440.30 ASO–Unspecified bypass graft/extremities
440.31 ASO–Autologous vein/bypass graft/
extremities
84.13 Disarticulation of ankle
84.14 Amputation of ankle through malleoli of tibia and
fibula
84.15 Other amputation–below ankle (minor
amputations)
84.16 Disarticulation of knee
84.17 Amputation–above knee
ALL 440.32 ASO–Non-Autologous vein/bypass graft/
extremities
444.22 Arterial embolism and thrombosis of LE
447.1 Stricture of artery
84.1 Amputations of lower limb
84.3 Revision of amputation stump
707.1 Ulcer of lower limb, except decubitus
707.9 Chronic ulcer of unspecified site
729.5 Pain in limb
730.06 Acute osteomyelitis–lower leg
730.07 Acute osteomyelitis–ankle and foot
730.16 Chronic osteomyelitis–lower leg
730.17 Chronic osteomyelitis–ankle and foot
785.4 Gangrene
996.74 Complication–vascular device thrombosis
997.62 Amputation–chronic infection stump
998.59 Post-op wound infection
250.7 Diabetes with peripheral circulatory disorders
*AAA – Aortic abdominal aneurysm.
**LER – Lower extremity revascularization.
***LE – Lower extremity.
